Denali Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

(NASDAQ:DNLI), SOUTH SAN FRANCISCO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (NASDAQ: DNLI) today announced the pricing of its underwritten public offering of 9,142,857 shares of its common stock at a price to the public of $17.50 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase […]

Denali Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

Denali Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants GlobeNewswire December 10, 2025 SOUTH SAN FRANCISCO, Calif., Dec. 10, 2025 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (NASDAQ: DNLI) today announced the pricing of its underwritten public offering of 9,142,857 shares of its common stock at a price to the public of

VFX AI Launches Alpha Release: One of the World's First AI-Native Video Platforms for Creators and Enterprises

VFX AI announces the Alpha release of its AI-native video platform, built to automate the entire video lifecycle from editing and reframing to hosting, distribution, and search. VFX AI’s Alpha release is designed to give creators, agencies, and enterprise teams a unified AI platform that dramatically accelerates video production while preserving brand quality and creative

Trio AI Partners with AbbyPay, a Member of PCG, to Pioneer the Future of AI-Powered Payments

As artificial intelligence (AI) rapidly permeates industries worldwide, Trio AI Limited ('Trio AI'), a leading AI infrastructure service provider in Asia, signed a Memorandum of Understanding ('MoU') with AbbyPay, a POS-free digital payment brand under The Payment Cards Group Limited ('PCG'), a cloud-native payment processor and acquirer, on November 26. This marks the official commencement

Canacol Energy Announces Agreement for Debtor in Possession (“DIP”) Financing

(TSX:CNE),(OTC US:CNNEF),(Other OTC:CNNEF),(BVC:CNEC),(BVC:CNEC.CL), CALGARY, Alberta, Dec. 09, 2025 (GLOBE NEWSWIRE) — Canacol Energy Ltd. (TSX: CNE) (OTCID: CNNEQ) (BVC: CNEC) (“Canacol” or the “Company”) announces that it has entered into an agreement with an ad hoc group of holders of the Company's 5.75% senior unsecured notes due 2028 (the “DIP Credit Agreement”) for debtor-in-possession financing

Canacol Energy Announces Agreement for Debtor in Possession (“DIP”) Financing

Canacol Energy Announces Agreement for Debtor in Possession (“DIP”) Financing GlobeNewswire December 10, 2025 CALGARY, Alberta, Dec. 09, 2025 (GLOBE NEWSWIRE) — Canacol Energy Ltd. (TSX: CNE) (OTCID: CNNEQ) (BVC: CNEC) (“Canacol” or the “Company”) announces that it has entered into an agreement with an ad hoc group of holders of the Company's 5.75% senior

Terns Announces Pricing of Upsized $650 Million Public Offering

(NASDAQ:TERN), FOSTER CITY, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced the pricing of its upsized underwritten public offering of 16,250,000 shares of its common stock at a public offering price of $40.00 per share, before underwriting discounts and commissions. The

Kymera Therapeutics Announces Pricing of Upsized $602 Million Public Offering

(NasdaqGM:KYMR), WATERTOWN, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced the pricing of its underwritten public offering of $602.0 million of shares of its common stock. Kymera is selling 7,000,000 shares of

Terns Announces Pricing of Upsized $650 Million Public Offering

Terns Announces Pricing of Upsized $650 Million Public Offering GlobeNewswire December 10, 2025 FOSTER CITY, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage oncology company, today announced the pricing of its upsized underwritten public offering of 16,250,000 shares of its common stock at a public

Scroll to Top